0001193125-12-234635.txt : 20120515 0001193125-12-234635.hdr.sgml : 20120515 20120515161855 ACCESSION NUMBER: 0001193125-12-234635 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120331 FILED AS OF DATE: 20120515 DATE AS OF CHANGE: 20120515 EFFECTIVENESS DATE: 20120515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BROOKSIDE CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001156175 IRS NUMBER: 043517087 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-06625 FILM NUMBER: 12844980 BUSINESS ADDRESS: STREET 1: JOHN HANCOCK TOWER STREET 2: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-516-2000 MAIL ADDRESS: STREET 1: JOHN HANCOCK TOWER STREET 2: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 d344711d13fhr.txt FORM 13F ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2012 Check here if Amendment [_]; Amendment Number: ________________________________ This Amendment (Check only one.): [_] is a restatement. [_] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Brookside Capital Management, LLC* Address: John Hancock Tower 200 Clarendon Street Boston, Massachusetts 02116 Form 13F File Number: 28-06625 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: William E. Pappendick IV Title: Managing Director Phone: (617) 516-2000 Signature, Place, and Date of Signing: /s/ William E. Pappendick IV Boston, MA 5/15/2012 ------------------------------- ---------------- ---------------------- [Signature] [City, State] [Date] * Brookside Capital Management, LLC is the general partner of Brookside Capital Investors, L.P., which is the general partner of Brookside Capital Partners Fund, L.P. Brookside Capital Management, LLC is also the general partner of Brookside Capital Investors II, L.P., which is the general partner of Brookside Capital Trading Fund, L.P. Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s). ================================================================================ Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 4 ---------- Form 13F Information Table Entry Total: 46 ---------- Form 13F Information Table Value Total: 4,373,080 ---------- (thousands)
List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. NO. FORM 13F FILE NUMBER NAME --- -------------------- -------------------------------------- 1 28-06924 Brookside Capital Investors, L.P. 2 28-06946 Brookside Capital Partners Fund, L.P. 3 28-13491 Brookside Capital Trading Fund, L.P. 4 28-13492 Brookside Capital Investors II, L.P. BROOKSIDE CAPITAL MANAGEMENT, LLC FORM 13F INFORMATION TABLE AS OF 03/31/2012
VOTING INVESTMENT OTHER AUTHORITY MARKET VALUE NAME OF ISSUER TITLE OF CLASS CUSIP LONG SHARES DISCRETION MANAGERS SOLE SHARED NONE ACHILLION PHARMACEUTICALS IN COM 00448Q201 15,607,803 1,629,207 X AKAMAI TECHNOLOGIES INC COM 00971T101 129,912,789 3,539,858 X ALLOT COMMUNICATION INC SHS M0854Q105 71,646,014 3,081,549 X AMARIN CORP PLC SPONS NEW ADR 023111206 27,973,678 2,471,173 X ANHEUSER BUSCH INBEV SA/NV SPONSORED ADR 03524A108 143,687,812 1,975,905 X AOL INC COM 00184X105 45,829,794 2,415,909 X APPLE INC COM 037833100 319,229,198 532,448 X ARIAD PHARMACEUTICALS INC COM 04033A100 31,960,000 2,000,000 X BRIGHTCOVE INC COM 10921T101 12,896,198 520,008 X CHECK POINT SOFTWARE TECH LT ORD M22465104 151,338,721 2,370,594 X CIENA CORP COM 171779309 85,432,784 5,276,886 X CTRIP COM INTL LTD AMERICAN DEP SHS 22943F100 114,260,304 5,280,051 X DIRECTV COM CL A 25490A101 126,744,839 2,568,805 X EASTMAN CHEM CO COM 277432100 100,679,198 1,947,750 X EL PASO CORP COM 28336L109 314,311,028 10,636,583 X E M C CORP MASS COM 268648102 204,580,292 6,846,730 X EXPRESS SCRIPTS INC COM 30219G108 146,040,402 2,695,467 X GOLAR LNG LTD BERMUDA SHS G9456A100 50,012,045 1,314,377 X GOOGLE INC CL A 38259P508 87,657,508 136,700 X HOME INNS & HOTELS MGMT INC SPON ADR 43713W107 31,163,118 1,221,604 X IDENIX PHARMACEUTICALS INC COM 45166R204 107,567,625 10,987,500 X KINDER MORGAN INC DEL COM 49456B101 96,625,000 2,500,000 X KOHLS CORP COM 500255104 25,045,018 500,600 X MACYS INC COM 55616P104 36,344,209 914,780 X MAP PHARMACEUTICALS INC COM 56509R108 43,073,193 2,999,526 X MCKESSON CORP COM 58155Q103 52,541,667 598,629 X MEAD JOHNSON NUTRITION CO COM 582839106 124,411,430 1,508,383 X MELCO CROWN ENTMT LTD ADR 585464100 82,293,244 6,033,229 X MICHAEL KORS HLDGS LTD SHS G60754101 305,745,664 6,562,474 X MONSANTO CO NEW COM 61166W101 156,025,316 1,956,185 X NANOSPHERE INC COM 63009F105 7,052,955 3,580,180 X NEOPHOTONICS CORP COM 64051T100 591,250 125,000 X NIELSEN HOLDINGS N V COM N63218106 66,852,871 2,218,078 X POLYCOM INC COM 73172K104 12,414,951 651,020 X POLYPORE INTL INC COM 73179V103 60,255,837 1,713,761 X SANDERSON FARMS INC COM 800013104 30,892,467 582,547 X SAP AG SPON ADR 803054204 84,750,169 1,213,838 X STREAM GLOBAL SVCS INC COM 86323M100 4,112,500 1,250,000 X TRANSDIGM GROUP INC COM 893641100 125,606,661 1,085,061 X TWO HBRS INVT CORP COM 90187B101 51,134,651 5,042,865 X VERIFONE SYS INC COM 92342Y109 122,985,689 2,371,037 X VERTEX PHARMACEUTICALS INC COM 92532F100 71,653,492 1,747,220 X VMWARE INC CL A COM 928563402 100,807,015 897,099 X VONAGE HLDGS CORP COM 92886T201 14,963,817 6,770,958 X YANDEX N V SHS CLASS A N97284108 62,796,668 2,337,055 X YOUKU INC SPONSORED ADR 98742U100 315,573,328 14,350,762***
***Ownership represents 1,862,857 ADS plus 224,782,288 ordinary shares convertible to ADS on an 18:1 basis***